Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
European Journal of Internal Medicine|April 16, 2023
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulationCelestino Sardu, Gianluca Gatta, Gorizio Pieretti, et al.Diabetes/Metabolism Research and Reviews|May 5, 2025
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients?Celestino Sardu, Nunzia D'Onofrio, Maria Consiglia Trotta, et al.American Journal of Preventive Cardiology|December 11, 2025
Endothelial dysfunction and cardiovascular outcomes in pre-menopausal women with high vs low breast fat accumulation: The role of TSP-1Celestino Sardu, Giovanni Francesco Nicoletti, Maria Consiglia Trotta, et al.Pharmacological Research|June 13, 2022
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical besideCelestino Sardu, Massimo Massetti, Lucia Scisciola, et al.Thescientificworldjournal|June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patientsSimona Signoriello, Annalisa Annunziata, Nicola Lama, et al.BMC Cancer|August 3, 2006
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trialSandro Pignata, Giovanni Scambia, Antonella Savarese, et al.Critical Reviews in Oncology/Hematology|December 28, 2007
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trialFrancesco Nuzzo, Alessandro Morabito, Ermelinda De Maio, et al.BMC Medicine|February 24, 2023
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetesRaffaele Marfella, Celestino Sardu, Nunzia D'Onofrio, et al.Cardiovascular Diabetology|August 5, 2022
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic heartsRaffaele Marfella, Nunzia D'Onofrio, Gelsomina Mansueto, et al.Critical Reviews in Oncology/Hematology|August 19, 2006
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)Sandro Pignata, Ciro Gallo, Bruno Daniele, et al.Pageof 11